ESR Essentials: staging and restaging with FDG-PET/CT in oncology—practice recommendations by the European Society for Hybrid, Molecular and Translational Imaging - Takeaways - MDSpire

ESR Essentials: staging and restaging with FDG-PET/CT in oncology—practice recommendations by the European Society for Hybrid, Molecular and Translational Imaging

  • By

  • Ricarda Ebner

  • Gabriel T. Sheikh

  • Matthias Brendel

  • Jens Ricke

  • Clemens C. Cyran

  • October 9, 2024

  • 0 min

Share

  • 1

    Proper patient selection for [18F]FDG-PET/CT is crucial, ensuring its use only when it surpasses conventional imaging in diagnostic accuracy.

  • 2

    [18F]FDG-PET/CT is effective in treatment planning and monitoring, detecting non-responding tumors early for timely treatment adjustments.

  • 3

    Combining [18F]FDG-PET/CT with other imaging modalities enhances diagnostic accuracy, particularly in evaluating liver metastases.

  • 4

    [18F]FDG-PET/CT significantly alters therapeutic management in about one-third of patients by providing higher diagnostic accuracy for metastases.

  • 5

    The integration of metabolic activity data from [18F]FDG-PET/CT with anatomical changes offers a comprehensive assessment of tumor response.

Original Source(s)

ESR Essentials: staging and restaging with FDG-PET/CT in oncology—practice recommendations by the European Society for Hybrid, Molecular and Translational Imaging

  • by Ricarda Ebner, Gabriel T. Sheikh, Matthias Brendel, Jens Ricke, Clemens C. Cyran

  • October 9, 2024

Related Content

CT-Based Assessment of Malignancy Risk in Part-Solid Pulmonary Nodules Utilizing Vascular Distortion and Interruption Analysis

The Most Sensitive Cancer Blood Test Yet

A CRISPR-powered light sensor detected trace amounts of cancer biomarkers in the blood

  • February 24, 2026

  • 2 min
Development of a CT-based comprehensive model with deep learning for differentiating pathological types of pulmonary ground-glass nodules